Search

Epilepsy and seizures exert a significant and enduring effect on sleep in epilepsy patients. Nocturnal generalised tonic-clonic seizures as well as multiple complex partial seizures distort sleep architecture and result in excessive daytime sleepiness. There is a lack of REM rebound in the successive nights. Furthermore, the chronic epileptic condition especially in focal epilepsy causes a disturbed sleep architecture independently of seizures. Epilepsy patients suffer from a 2- to 3-fold increased prevalence of subjective sleep disturbances as compared to the general population. Sleep disturbances are associated with a significant impairment in quality of life. Children with epilepsy suffer from sleep prob-lems more often than healthy children. Sleep impairment in children with epilepsy causes behavioural problems and reduced quality of life. With a prevalence of 30-50% excessive daytime sleepiness represents the most frequent sleep-related disturbance in epilepsy patients and could be documented with objective tests. Obstructive sleep apnea (OSA) occurs in 10-33% of epilepsy patients and thus significantly more often than in the general population. Possible mechanisms include the effects of central nervous system depressant antiepileptic drugs, weight gain in-duced by antiepileptic drugs and the increased incidence of polycystic ovary syndrome in women with epilepsy. OSA can lead to an exacerbation of seizures. On the contrary, successful treatment of OSA results in improved seizure control.

A retrospective study of 316 patients (173 men, 143 women; mean age 39 [17-87] years) who had taken antiepileptics (phenytoin, phenobarbital, carbamazepine, valproic acid) for at least six months, was carried out to assess the biochemical and haematological changes in relation to the drug used, the therapeutic programme and the drug serum levels. The most frequent change was isolated elevation of gamma-GT (9-89% of cases depending on the drug), followed by elevation of alkaline phosphatase (16-44%). Increases in the transaminases GOT (4-13%) and GPT (4-19%) were infrequent and minor. Changes in the blood picture were very infrequent and never more than minimal. Correlation between all these changes and serum drug levels was poor (r less than 0.15). Correlations between drug serum level and dose were found in the case of phenobarbital (r = 0.6) and valproic acid (r = 0.5). There was hence no evidence of any clear connection between the biochemical findings and the serum concentrations of antiepileptic drugs or their-dosage. The results indicate that undue importance has previously been attached to routine checks of biochemical parameters; abnormal biochemical findings by themselves are not usually enough to necessitate changes in treatment. Determination of biochemical and haematological parameters is necessary only if there are clinical grounds for it such as suspicion of side effects, the occurrence of epileptic attacks despite therapy, or change from one drug to another.

Background: Dopaminergic and opioidergic drugs have been found to be effective in patients with restless legs syndrome (RLS). Objectives: To test the effect of apomorphine—a combined opioidergic and dopaminergic agonist—and subsequent selective antagonism by naloxone and metoclopramide on subjective and objective symptoms in patients with idiopathic RLS. Methods: Nine patients with RLS were pretreated with oral domperidone for three days. A modified suggested immobilisation test (SIT) was carried out between 8 pm and 1 am under the following conditions of intravenous drug administration: baseline–apomorphine–apomorphine plus naloxone–apomorphine plus metoclopramide. Outcome variables were a visual analogue scale (VAS) of subjective RLS symptoms and EMG documented periodic leg movements while awake (PLMW). Results: Compared with baseline, apomorphine resulted in a rapid and significant improvement in subjective RLS symptoms as measured by VAS (54.5% improvement; p = 0.011), and an almost immediate cessation of PLMW, measured by PLMW index (98.0% improvement; p = 0.012). Neither additional naloxone nor metoclopramide blocked this effect significantly. While given apomorphine with metoclopramide, there was a trend to reappearance of PLMW. Conclusions: Apomorphine may be an effective treatment for idiopathic RLS. Its effectiveness may reflect both to its dopaminergic and its opioidergic activity, and is not diminished significantly by blocking only one of these pathways. The trend to a worsening of the PLMW index with metoclopramide hints at a primarily dopaminergic effect of apomorphine in idiopathic RLS.

Objectives: To gain reliable data on sleeping habits and sleep disturbances of the Austrian population. Background: Exact data on sleeping habits are of interest in relation to assessment of sleep disturbance-related illnesses and general social processes. Methods: A prospective, cross-sectional study was performed with recruitment of a representative sample of 1049 Austrians (aged 15–82 years), according to the Federal Statistics population characteristics. Interviews were conducted in the households of the participants by specially trained interviewers of an institute for empirical research. Results: Men consider their quality of sleep to be significantly better than women (P=0.00234), and younger persons consider their quality of sleep to be significantly better than older persons (P=0.00001). In comparison, women and people over the age of 50 report worse subjective sleep quality, worse sleep efficiency, more difficulty in falling asleep and sleep maintenance, more apneic events, more pathologic limb movements, more daytime dysfunction, and more intake of sleeping medication. Other sociodemographic factors influence sleep reports to a lesser extent. Conclusions: Subjectively disturbed sleep (prevalence in the total population 24.9%), excessive hypnotic drug intake (prevalence 13.0%), and daytime dysfunction (prevalence 17.4%) are a widespread problem, especially in women and older people. With increasing life expectancy in Western societies, the prevalence of sleep disturbances will increase.

Zusammenfassung: Vorliegende Literaturubersicht zeigt den derzeitigen Wissensstand uber gesundheitliche Folgen von statischen und niederfrequenten elektrischen und magnetischen Feldern und von hochfrequenten elektromagnetischen Feldern (bis zu einer Frequenz von 300 GHz) fur den Menschen. Zunachst werden die wichtigsten physikalischen Grundkenntnisse und die derzeit gultigen Grenzwertbestimmungen erortert. Anschliesend werden, getrennt fur die unterschiedlichen Frequenzbereiche, naturliche und technische Quellen sowie die unterschiedlichen biologischen Auswirkungen mit Schwerpunkt auf potentiell gefahrdende Folgen wie Kanzerogenitat oder Einflus auf das Gehirn dargelegt. Offene Fragen und zukunftiger Forschungsbedarf werden dargelegt. Abschliesend folgen Betrachtungen uber Elektrosensibilitat und uber psychologische Aspekte.

A double-blind, placebo-controlled, parallel-group, multicentre study was conducted to evaluate the efficacy of pentoxifylline (Trental) in patients with multi-infarct dementia (MID) according to DSM-III-R criteria. Men and women aged 45 years or older, with a Hachinski Ischemia Scale scoreor = 7 and a Mini Mental State Examination (MMSE) score of 10-25 at entry, and computed tomographic evidence of vascular disease were enrolled. A total of 289 patients were randomised to receive either oral pentoxifylline 400 mg t.i.d. or placebo for 9 months, and efficacy was assessed every 3 months. The primary outcome variable was the difference in scores between the two treatment groups, as measured on the Gottfries, Bråne, Steen (GBS) scale. Secondary outcome variables included the scores achieved on the Sandoz Clinical Assessment Geriatric (SCAG) scale and MMSE, and a battery of psychological and other tests. The intention-to-treat analysis for patients completing the study (n = 239) showed a statistically significant difference in the total GBS score in favour of pentoxifylline (improvement of 3.5 points, p = 0.028). A significant difference in the total GBS score in favour of pentoxifylline was even almost achieved in the intention-to-treat analysis for all evaluable patients (n = 269, improvement of 2.1 points, p = 0.065). It is concluded that treatment with pentoxifylline is beneficial for patients with MID, the global results of the GBS and SCAG scales being reinforced by significant improvements in those subscales specific for intellectual and cognitive function.

In a prospective study, an elderly group of patients (n = 63, 47 male, 16 female, age 40–65 years) was examined before and after open-heart surgery under cardiopulmonary bypass: postoperatively, 19 patients (30%) showed no clinical neuropsychiatric symptoms, whereas in 35 patients (56%) mild or transient neurological signs and in nine (14%) severe neurological complications were found. The postoperative EEG changes were characterized by a slight delta-theta increase, an alpha decrease and a significant cant slowing of the dominant frequency from 9.7 to 9.3 Hz. In brainstem auditory evoked potentials no changes were found, and in somatosensory evoked potentials (median nerve) the latency of the early cortical component, N20, increased. Cardiovascular reflexes showed increased changes, similar to those found in autonomic neuropathies. In the neuropsychological test battery, the Visual retention test (Benton) and the Rorschach test showed slight postoperative improvement, whereas other psychometric variables (flicker fusion frequency, reaction time) did not change. Despite an improved operative technique some minor clinical and neurophysiological disturbances of the central nervous system remain. However, specific pre- or peri-operative risk factors for these postoperative disturbances or complications could not be identified.

We report on two siblings, a boy and a girl, with agenesis of corpus callosum and neuronopathy. The children show diffuse hypotonia, delayed motor and mental development. Neurophysiological examinations revealed reduction of the motor nerve conduction velocity, absence of sensory nerve action potentials, abnormal somatosensory and visual evoked potentials. Nerve biopsies showed reduced density of myelinated and unmyelinated fibres in both children. We also found signs of hypomyelination and suggest this is secondary to degeneration of peripheral sensory and motor neurons. Our findings are consistent with the diagnosis of Andermann syndrome. This is the first report of the occurrence of Andermann syndrome out of French Canada.

Stage 2 sleep spindles have been previously viewed as useful markers for the development and integrity of the CNS and were more currently linked to 'offline re-processing' of implicit as well as explicit memory traces. Additionally, it had been discussed if spindles might be related to a more general learning or cognitive ability. In the present multicentre study we examined the relationship of automatically detected slow (13 Hz) and fast (13 Hz) stage 2 sleep spindles with: (i) the Raven's Advanced Progressive Matrices (testing 'general cognitive ability'); as well as (ii) the Wechsler Memory scale-revised (evaluating memory in various subdomains). Forty-eight healthy subjects slept three times (separated by 1 week) for a whole night in a sleep laboratory with complete polysomnographic montage. Whereas the first night only served adaptation and screening purposes, the two remaining nights were preceded either by an implicit mirror-tracing or an explicit word-pair association learning or (corresponding) control task. Robust relationships of slow and fast sleep spindles with both cognitive as well as memory abilities were found irrespectively of whether learning occurred before sleep. Based on the present findings we suggest that besides being involved in shaping neuronal networks after learning, sleep spindles do reflect important aspects of efficient cortical-subcortical connectivity, and are thereby linked to cognitive- and memory-related abilities alike.

Sleep disorders and depression are frequent in patients with Parkinson's disease (PD). However, the exact prevalence and the causality are still unknown.We interviewed 56 consecutive PD patients and 59 age-matched healthy controls concerning sleep disorders and depression. Sleep Disorders Questionnaire (SDQ) and Zung Depression Scale (ZDS) were used as standardized valid and reliable psychometric tests.Patients with PD had significantly higher values in the clinical-diagnostic scale narcolepsy (P=0.01), correlating with the L-dopa dose (P=0.007). Concerning sleep apnea (P=0.49), psychiatric sleep disorder (P=1.00) and periodic limb movement disorder (P=0.12), no significant difference could be identified. PD patients showed significantly higher depression scores than healthy control subjects (P=0.01), increasing with the duration of PD (P=0.04).The significant higher narcolepsy score in PD patients must be seen due to dopaminergic medication and PD-specific neurodegeneration and immobility rather than due to narcolepsy. This leads to the conclusion that extreme caution is advised when carrying out the SDQ and interpreting the results in various persons and patient groups with motor problems. The strong association of depression, disease severity and sleep disorders in PD patients underlines the importance of identifying and treating both conditions in these patients.

In myasthenia gravis respiratory function is often disturbed in the night, especially during REM sleep, despite of normal daytime respiratory function. Nevertheless, nocturnal respiratory problems are rarely diagnosed. Sleepiness, concentration and memory problems can be symptoms of a sleep related breathing disorder. Reports of reduction of REM sleep, memory dysfunction, and detection of acetylcholine receptor (AchR)-antibodies in the cerebrospinal fluid have lead to the hypothesis of a central nervous system involvement in myasthenia gravis. Possible mechanisms are centrally acting AchR-antibodies, unspecifically acting cytokines and hypoxia, possibly the most important influence upon REM sleep reduction and impaired cognitive function. In a patient presenting possible CNS-involvement (cephalea, fatigue, concentration and memory problems), a polysomnographic investigation should therefore be performed to detect a sleep related breathing disorder.

Headaches and sleep disorders are frequent and can be associated with each other. Some headache syndromes are related to certain sleep phases or circadian rhythms. These so-called sleep-related headache syndromes include specific types of migraine, cluster headache, chronic paroxysmal hemicrania, and the hypnic headache syndrome. Except for the latter, they were included in the International Classification of Sleep Disorders and are described in this article.

To compare the self-reported estimation of sleep quality evaluated by the Pittsburgh Sleep Quality Index (PSQI) and life quality assessed by the Quality of Life Index (QLI).The PSQI comprised 19 questions and assessed a wide variety of factors relating to sleep quality. The QLI consisted of 10 items for self assessment of different dimensions of life quality.A representative Austrian sample (n = 1049) aged above 15 years.Interviews in the homes of the participants.32.1% could be classified as poor sleepers (37% females, 26.5% males). Sleep quality decreased with increasing age, especially in women. Overall quality of life was highest in younger (15-29 years) and lowest in elderly subjects (over 50 years). Life quality decreased with increasing age. Between subjective sleep quality and quality of life a moderate, significant correlation was found (r2= 0.6721).Complaints about a bad quality of sleep could be used as a screening method in the exploration of patients' quality of life (QoL).

To evaluate the safety of edrophonium chloride in the course of the Tensilon test by measurement of hemodynamic and ECG parameters and the observation of adverse events.25 patients with known or suspected myasthenia gravis were included in an open, prospective study concerning the performance of the Tensilon test. Blood pressure, heart rate, continuous ECG and adverse events were recorded 10 minutes following intravenous application of Tensilon.Blood pressure and heart rate did not change significantly during the observation period. One patient on beta-blockers developed a grade I AV block. Self-limiting adverse events of short duration were observed in 11 patients. Serious adverse events such as syncope or hemodynamic deterioration did not occur.The Tensilon test appears to be a safe procedure. A detailed clinical cardiac history, the history of medication and twelve lead ECG recordings should be documented in all patients undergoing the Tensilon test. Patients with a history of dysrhythmia receiving digitalis, beta-blocking agents or Ca antagonist therapy should be managed with special care, as Tensilon enhances vagal effects.

This literature review shows the current knowledge of health effects on humans concerning static, low frequency electric and magnetic fields and high frequency electromagnetic fields up to 300 GHz. Basic physical knowledge and the current thresholds are demonstrated. Different frequency ranges of electromagnetic fields, their natural and technical origins and the different biological effects, especially possible hazards such as cancerogenity or risks for the brain, are discussed. Open questions and future research aspects are demonstrated. Finally electrosensibility and psychological aspects are shown.

We investigated thyroid function and autoimmunity in 74 (61% females) consecutive patients with MG. 30 of these patients were tested twice: the time between the investigations ranging from 1 to 4 years. MG was diagnosed on the basis of typical clinical symptoms, a positive tensilone-test, and/or detectable acetylcholine antibodies and/or repetetive stimulation tests. Eye involvement was present in 86%, concurrent thymomas in 56%. The following parameters were measured in the serum of these patients by commercially available kits: free and total T4, TSH, TSH-Receptor-Antibodies ("TRAB"), antibodies against thyroglobulin (Tg-Ab), against thyroid microsomes (M-Ab) and against acetyl-choline-receptors . An age matched group of 50 patients (54% females) with no known thyroid disease from a cardiological ward and from the neurological outpatient department served as control. There was only 1 MG patient with overt thyroid dysfunction (iodine induced thyrotoxicosis in a patient with autonomous adenoma and no circulating thyroid autoantibodies detected at the second investigation). There were, moreover, 1 euthyroid MG-patient on L-thyroxine therapy with a history of Hashimoto's disease and positive thyroid autoantibodies and 1 other MG-patient with mildly elevated TSH without elevated thyroid antibodies, who has had subtotal thyroidectomy without substitution therapy years before for unknown reasons. Tg-Ab were positive (>360 IU/ml) in 5%, M-Ab were positive (>154 IU/ml) in 15% of the MG patients. The control group had 4% Tg-Ab and 6% M-Ab. TRAB levels were normal in all patients and controls. The relative increase in M-Ab frequency was not statistically significant (x-square test). We conclude from our results, that autoimmune thyroid disease may be associated with MG but that the occurrence of thyroid dysfunction induced by autoimmunity is a very rare phenomenon in MG.

Transarterial EEG-recording is a complementary method to surface and depth-techniques. In 8 patients having superselective angiography because of diagnosis or therapeutic manoevres transarterial EEG-recording was performed. There were only few artefacts and no clinical side effects. The value of this additional information is discussed

Hypersomnia (excessive sleepiness) accompanies many diseases. 14% of the total Austrian population regularly have problems staying awake during the day or are prone to taking spontaneous naps. Hypersomnia is a symptom of the sleep apnea syndrome, which is a risk factor for cerebrovascular disorders. Daytime sleepiness is also a characteristic symptom of narcolepsy, idiopathic hypersomnia, episodic hypersomnia, and many more neurological or psychiatric disorders; it can also be drug induced. Involvement of brain structures which are essential for the regulation of the sleep wake cycle as a result of neurological disorders can likewise lead to hypersomnia. Symptomatic treatment is necessary when treatment of the causal factors is not possible or no improvement has been achieved.

19 middle-aged patients with myasthenia gravis (MG) and 10 age-matched controls underwent overnight polysomnography and neuropsychological testing, in order to assess the frequency, degree, type and risk factors of sleep apneas in MG and to show their influence on sleep profile and neuropsychological variables. We observed in 60% of the myasthenics, low grade central type of sleep apneas and hypopneas with resulting oxygen desaturations, occasionally occurring during REM-sleep without influence on sleep profile and vigilance but resulting in significant memory impairment. The only found risk factor for the development of sleep apneas was age.

Amyotrophic lateral sclerosis is a progressive degenerative disease of upper and lower motor neurons with a prevalence of 4.3/100.000. The clinical symptoms include peripheral weakness and central spastic paresis and bulbar paralysis (weakness of mimic muscles, atrophy of the tongue, dysarthria). The prognosis leads to death within a few years. Pathogenetic factors are free O2-radicals, a disturbance of glutamate-metabolism, abnormal accumulation of neuronal proteins and autoimmunological mechanisms.

In diesem Abschnitt soll das Zusammenspiel von physischen und psychischen Vorgangen dargestellt werden. Der Schwerpunkt liegt weniger auf der Beschreibung der einzelnen Organfunktionen, es soll vielmehr auf die gegenseitige Einflusnahme von physischen und psychischen Prozessen hingewiesen werden; welchen Einflus haben psychische Befindlichkeiten, wie Affekte und Emotionen auf unseren Organismus und welche Auswirkungen haben umgekehrt organische Prozesse auf unser psychisches Befinden und Verhalten.

Die klassische Schlafstadienklassifizierung basiert nur auf einer EEG-Ableitung (C4/A1 oder C3/A2) sowie auf 2 EOG- und 1 EMG-Ableitung. Topographische Unterschiede wurden als unwichtig angesehen und waren wegen der Datenmenge auch technisch schwierig auswertbar.

Sleep apnea and snoring are widely discussed as risk factors for internal and neurological diseases. The prevalence of snoring in an Austrian population survey is about 27.2% (males 36.5%, females 18.9%), and that of apnea (respectively irregularity and/or cessation of breathing) about 8.5% (31% of all snorers). Clinical symptoms like naps, daytime sleepiness, unquiet sleep, hypertonia, headache in the morning and psychological symptoms may be characteristics of sleep apnea. They should lead to further diagnosis and removal of this risk factor for ischemic heart disease and stroke.

Die Einfuhrung der SPECT (single photon emission tomography) Technik in die Medizin erlaubt eine nicht invasive, dreidimensionale Darstellung der cerebralen Durchblutung. Der dafur in den letzten Jahren haufig verwendete, mit 99mTechnetium radioaktiv markierte Tracer, das Hexamethyl-propylene-amine-oxime (HMPAO), lagert sich dabei entsprechend den intracerebralen Perfusionsverhaltnissen ab. Dies last Ruckschlusse auf regionale cerebrale Aktivierungen zu.

Epidemiologic data on sleep disturbances in Austria were collected for the first time in March/April 1993 in a representative inquiry (n = 1000, 471 males, 529 females). 26% of the subjects reported sleep disturbances which were mostly chronic (21% had suffered from sleep disturbance for more than one year). The incidence of sleep disturbances increased with age, namely 13% in 14-30 year-old subjects, 22% in 31-50 year-old ones and 41% in subjects over 50. 7% suffered from disturbances in sleep initiation, i.e., they had a sleep latency of over 30 minutes. 19% of them had difficulties in getting to sleep at least once a week. Disturbances in maintaining sleep were reported by 28% of subjects, 56% of them needing longer than one hour to get back to sleep. 30% suffered from daytime sleepiness, 43% of the subjects were impaired by their sleep disturbances in some way, but only 34% had consulted their doctor.

Sleep disturbances are an important health problem; about 20-33% of the population suffer from hyposomnias (lack of sleep). Hyposomnias often accompany neurological disorders (head traumas, chronic cephalea, pain, cerebrovascular and neuromuscular disorders, M. Parkinson, and dementia). Slow wave sleep decreases, arousals increase, and sleep is fragmented; these types of hyposomnias are treated by treatment of the basic neurological disease. Some sleep disturbances (e.g. sleep apneas) are a risk factor for cerebrovascular disorders.

We studied somatotopy of human hand somatosensory cortex using evoked responses recorded on magnetoencephalogram (MEG) and scalp-electroencephalogram (EEG) in conjunction with dipole modeling. We found a somatotopic arrangement of cortical digit representations with a sensory sequence from lateral inferior to medial superior in the anatomical order thumb, index finger, middle finger, ring finger, and little finger. MEG alone was able to reproduce this sensory sequence more accurately than scalp-EEG alone. However, the combined information provided by both techniques improved localization accuracy even further. As MEG and scalp-EEG are complementary and confirmatory techniques, this combined approach was useful to get more complete information on the functional organization of human hand somatosensory cortex.

In order to investigate functional topography of human hand somatosensory cortex we recorded somatosensory evoked fields (SEFs) on MEG during the first 40 ms after stimulation of median nerve, ulnar nerve, and the 5 digits. We applied dipole modeling to determine the three-dimensional cortical representations of different peripheral receptive fields. Median nerve and ulnar nerve SEFs exhibited the previously described N20 and P30 components with a magnetic field pattern emerging from the head superior and re-entering the head inferior for the N20 component; the magnetic field pattern of the P30 component was of reversed orientation. Reversals of field direction were oriented along the anterior-posterior axis. SEFs during digit stimulation showed analogous N22 and P32 components and similar magnetic field patterns. Reversals of field direction showed a shift from lateral inferior to medial superior for thumb to little finger. Dipole modeling yielded good fits at these peak latencies accounting for an average of 83% of the data variance. The cortical digit representations were arranged in an orderly somatotopic way from lateral inferior to medial superior in the sequence thumb, index finger, middle finger, ring finger, and little finger. Median nerve cortical representation was lateral inferior to that of ulnar nerve. Isofield maps and dipole locations for these components are consistent with neuronal activity in the posterior bank of central fissure corresponding to area 3b. We conclude that SEFs recorded on MEG in conjunction with source localization techniques are useful to investigate functional topography of human hand somatosensory cortex non-invasively.

In 63 patients undergoing heart operations with extracorporeal circulation (47 males, 16 females, mean age 54 years; coronary artery bypass in 38 cases, valvular surgery in the rest) postoperative neurological and psychiatric complications were evaluated. 18 patients (29%) had no complications, whereas 35 patients (56%) showed minor or transient neurological symptoms, and 9 patients (14%) exhibited severe symptoms. Nine of the patients had slight psychiatric disturbances (affective disturbances, disorientation). No correlation was found between risk factors (age, nicotine abuse, hypertension, hypercholesteremia, neurologic and cardiac history), intraoperative parameters (duration of extracorporeal bypass, aortic clamp time, deviation of mean arterial pressure), postoperative parameters (internal complications) and the complication rate. Therefore no predisposing factors could be identified.

In 22 patients with apallic syndrome brainstem auditory and somatosensory evoked potentials were recorded, in 8 patients the course during rehabilitation was observed. Clinically the patients were scored with Glasgow-coma scale, Karnofsky-index and Goldenberg-scale. The outcome of rehabilitation was estimated by the "Glasgow-outcome scale". No correlation was found between results of evoked potentials and clinical state. First evoked potentials measurements of apallic patients allowed no prognosis. Evoked potentials are an important prognostic factor after severe head trauma, but have no value for the prognosis of apallic patients.

A retrospective study of 316 patients (173 men, 143 women; mean age 39 [17-87] years) who had taken antiepileptics (phenytoin, phenobarbital, carbamazepine, valproic acid) for at least six months, was carried out to assess the biochemical and haematological changes in relation to the drug used, the therapeutic programme and the drug serum levels. The most frequent change was isolated elevation of gamma-GT (9-89% of cases depending on the drug), followed by elevation of alkaline phosphatase (16-44%). Increases in the transaminases GOT (4-13%) and GPT (4-19%) were infrequent and minor. Changes in the blood picture were very infrequent and never more than minimal. Correlation between all these changes and serum drug levels was poor (r less than 0.15). Correlations between drug serum level and dose were found in the case of phenobarbital (r = 0.6) and valproic acid (r = 0.5). There was hence no evidence of any clear connection between the biochemical findings and the serum concentrations of antiepileptic drugs or their-dosage. The results indicate that undue importance has previously been attached to routine checks of biochemical parameters; abnormal biochemical findings by themselves are not usually enough to necessitate changes in treatment. Determination of biochemical and haematological parameters is necessary only if there are clinical grounds for it such as suspicion of side effects, the occurrence of epileptic attacks despite therapy, or change from one drug to another.

The frequency of epileptiform discharges shows a wide intraindividual variability; it is influenced by the sleep-waking cycle and by the different stages of sleep: generalized seizures (tonic-clonic, tonic and myoclonic) are activated in nonrapid eye movement sleep, partial seizures tend to have more complex relationships with sleep states. Generally, sleep stages I and II and transit stages have an activating effect on discharges. Rapid eye movement sleep has an "anticonvulsive" effect and focalizes paroxysmal activity. Sleep recordings are useful for localizing a focus in temporal lobe seizures and for differentiation of epileptic seizures from non-epileptic seizure-like sleep disturbances. EEG after sleep deprivation should be used in patients suspected of suffering from epilepsy whose prior EEGs (including hyperventilation, photic stimulation and short sleep) were normal or yielded borderline abnormalities. Epileptiform discharges can--without clinical seizures--produce arousal reactions and sleep disturbances.

A 32-year-old male patient with chronic myelocytic leukemia in accelerated phase received a bone marrow allograft from his 42-year-old HLA/MLC-identical sister. He recovered from acute graft-versus-host disease (GVHD) grade III-IV of skin, liver and gut, but chronic GVHD of progressive onset developed. On day 556 post-graft severe thrombocytopenia was resistant to prednisolone, cyclophosphamide and high dose immunoglobulin. Splenectomy was followed by a normalization of platelet counts. The subsequent clinical course was characterized by progressive muscular atrophy and weight loss. Dysphagia, dysarthria, cachexia and ultimately recurrent pneumonic episodes ensued. The cachectic patient developed a highly abnormal breathing pattern with hypoventilation and intermittent apnea requiring mechanical ventilation. Auditory evoked potentials revealed a considerable dysfunction of the brainstem. The patient died on day 1120 post-graft from pneumonia, aggravated by thoracic muscular insufficiency. Postmortem examination revealed diffuse predominantly lymphoid perivascular infiltration in meninges and CNS tissue; proliferation of activated microglial cells expressing the HLA-DR antigen was prominent in the brainstem. These histologic changes are similar to those observed in the CNS in experimental GVHD. We suggest that this case represents the first documentation of CNS involvement in chronic GVHD.

Five potential organ donors showed muscle artefacts during isoelectrical EEG recording. The electromyographic examination revealed MUAP activity occurring as doublets, triplets and quadruplets. All patients had normal blood chemistry except reduced CO2 and increased O2 partial pressures. We assume that the recorded "tetaniform" muscle activity is due to hyperexcitability of the nerve membrane caused by artificial hyperventilation.

Transarterial EEG-recording is a complementary method to surface and depth-techniques. In 8 patients having superselective angiography because of diagnosis or therapeutic manoeuvres transarterial EEG-recording was performed. There were only few artefacts and no clinical side effects. The value of this additional information is discussed.

34 ambulatory polygraphic sleep-records of young adults were carried out using the Oxford Medilog 9000 recorder. All of the records underwent automatic evaluation by the Oxford Sleep Stager. 10 cases were, in addition, evaluated visually. 4 records could not be analyzed because of artifacts. Thus, 30 subjects were used in the end for establishing standard values of sleep parameters. Automatic versus automatic comparisons and automatic versus visual comparisons of ten polysomnograms were performed epoch-by-epoch. The automatic versus automatic comparison showed agreement in 85.5% of epochs, and the automatic versus visual comparison in 70.4% of epochs. The Sleep Stager showed the best agreement with the visual evaluation in epoch-by-epoch comparison in the REM-stage (93.9%), the worst in stage 1 (32.4%). In calculating the percentages of total night sleep for the respective sleep stages, the automatic analysis showed strongest disagreement with visual evaluation in the REM-stage (plus 7.5%) and in stage 2 (minus 5.2%).

Der Hirntod ist als irreversibler Ausfall der Groshirn- und Hirnstammfunktion definiert. Daruber hinaus mus die Irreversibilitat dieses Funktionsausfalles nachgewiesen sein [11]. Durch zunehmende Moglichkeiten der Intensivmedizin wie kunstliche Beatmung und Stabilisierung des Herzkreislaufsystems konnen die wichtigsten basalen Vitalfunktionen auch noch aufrechterhalten werden, wenn bereits ein irreversibler Funktionsausfall des Gehirns angenommen werden mus (dissoziierter Hirntod).

At the moment evoked potentials in Austria are not admitted for diagnosing brain death. Brainstem auditory evoked potentials are proving the loss of the brainstem function, if a primary supratentorial lesion is excluded and if they disappear bilaterally and stepwise. The early components of somatosensory evoked potentials after median nerve stimulation allow the examination of the brainstem and the cortical function, if medullary lesions are excluded. In our study evoked potentials were recorded in 23 patients with bulbar brain syndrome and isoelectric EEG: In 21 (47%) of the 45 examined hearing pathways a component I and in 3 pathways (7%) a component II was found. In 41 examined pathways of median nerve a complete loss of the spinal response was observed in 12 pathways, whereas in 29 pathways (71%) the spinal response was preserved.

In a prevalence study of 335 psychiatric in-patients 49 patients (14.6%) with tardive dyskinesia were found. In view of the high prevalence of spontaneous dyskinetic syndromes in elderly patients only patients under 60 years were included (n = 21; mean age: 44.9). Clinical rating was performed with the AIMS-scale. CT measurements of ventricular enlargement and cortical atrophy were obtained. Tardive dyskinesia cases did not differ significantly from healthy controls, though some patients with severe dyskinesia showed signs of brain atrophy. These findings did not provide evidence to support neuropathological reports describing neuronal cell loss and midbrain gliosis in such patients. It is concluded that such structural brain changes in tardive dyskinesia patients are not detectable with present CT technology: they may either be due to concurrent aging processes or, in the case of younger patients, can be confirmed only by more functional methods of testing.